IL10 and systemic sclerosis: They also demonstrate that IL-10-producing B cells and IL-10 secretion by stimulated B cells are reduced in SSc patients, which can imply that these patients have an impaired anti-inflammatory function on regulatory B cells, a subset specifically dedicated to promote tolerance to innocuous antigens.